Identification of a Novel Subtype of Ocular Hypertensive Eyes with the Lowest Risk of Progression Under Treatment.

Abstract

Authors

• Asma Poursoroush
  Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, TN.
• Vida Abedi
  Department of Public Health Science, Penn State College of Medicine, Hershey, PA, USA.
• Xiaoqin Huang
  The Pennsylvania State University Great Valley, Malvern, PA, USA.
• Jiang Li
• Alireza Vafaei Sadr
  Uniklinik RWTH Aachen, Aachen, North Rhine-Westphalia, Germany.
• Amy L de Jongh Curry
  Department of Biomedical Engineering, University of Memphis and University of Tennessee Health Science Center, Memphis, USA.
• Louis R Pasquale
  Eye and Vision Research Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
• Michael V Boland
  Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
• Chris A Johnson
  Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA, USA.
• Siamak Yousefi
  Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America.

Keywords

No keywords available for this article.

External Resources